Compare IRWD & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | VPG |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.6M | 552.5M |
| IPO Year | 2009 | 2010 |
| Metric | IRWD | VPG |
|---|---|---|
| Price | $3.52 | $118.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $53.50 |
| AVG Volume (30 Days) | ★ 2.6M | 607.4K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1400.00 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | $298,276,000.00 | ★ $307,202,000.00 |
| Revenue This Year | $57.95 | $7.21 |
| Revenue Next Year | $4.39 | $6.92 |
| P/E Ratio | $15.00 | ★ N/A |
| Revenue Growth | ★ 8.88 | 0.22 |
| 52 Week Low | $0.56 | $24.89 |
| 52 Week High | $5.78 | $131.68 |
| Indicator | IRWD | VPG |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 75.80 |
| Support Level | $3.07 | $32.38 |
| Resistance Level | $3.92 | N/A |
| Average True Range (ATR) | 0.23 | 9.88 |
| MACD | -0.05 | 2.48 |
| Stochastic Oscillator | 13.83 | 81.06 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.